XPeng (XPEV) Stock Dips Despite Debut of IRON Humanoid Robot Production

Key Takeaways

• Shares of XPEV declined more than 2% even as the company’s first IRON humanoid robot successfully completed automated assembly and exited the production line independently
• Commercial rollout of IRON is scheduled for early 2027 across Chinese and international markets
• Over 80% of manufacturing processes on the production line utilize automation, leveraging technology borrowed from automotive manufacturing
• The company’s robotics division Dogotix secured $900 million in funding last month, pushing its valuation above $6.3 billion
• UBS launched coverage on XPEV with a neutral stance and HK$47.00 price target, recognizing robotics potential while noting EV sector headwinds

XPeng’s inaugural IRON humanoid robot successfully walked off the assembly line autonomously, yet market sentiment remained negative. XPEV shares dropped approximately 2.2% during Wednesday’s session, hovering around $10.69, dangerously close to its 52-week bottom of $10.72. The stock has plunged more than 40% since the beginning of the year.

XPeng Inc., XPEV

This achievement signals XPeng’s transition from research and development in humanoid robotics toward volume manufacturing. The robot successfully navigated through the automated final assembly sequence and departed the line independently.

IRON features a biomimetic “bone-muscle-skin” architecture incorporating a flexible spinal column, artificial muscle systems, soft epidermis covering the entire body, and 22 degrees of freedom in its hand mechanisms. The robot operates using a physical-world foundation model driven by three Turing AI processors.

The platform integrates visual perception, natural language processing, and movement capabilities via a multi-brain artificial intelligence framework. XPeng characterizes it as the “most anthropomorphic humanoid robot” in its portfolio.

XPeng’s internal engineering team designed and constructed the production facility, incorporating manufacturing processes and quality assurance protocols derived from automotive sector experience. Automation accounts for over 80% of critical production stages.

The company intends to launch commercial operations of IRON in domestic Chinese markets and international territories by the first quarter of 2027. Early deployment will focus on hazardous and monotonous tasks before expanding into wider use cases.

Robotics Division Secures $900 Million

In the previous month, Dogotix, XPeng’s robotics subsidiary, completed a $900 million private financing round. The investment established Dogotix’s valuation at more than $6.3 billion.

Bank of America maintained its Buy recommendation with a $19.00 target price following the funding news.

UBS Launches Coverage

Coinciding with the production achievement, UBS began coverage of XPEV with a neutral assessment and a target of HK$47.00. Analyst Paul Gong noted that XPeng ranks among the most aggressive robotics participants within China’s automotive sector.

UBS employed a sum-of-the-parts methodology, allocating 30% of overall value to robotics operations. The firm acknowledged XPeng’s success in establishing $4.3 billion in robotics value through its fundraising efforts.

Nevertheless, UBS highlighted obstacles in the primary automotive business, referencing fierce competition, supply chain disruptions, and abbreviated product lifecycles. XPeng continues operating at a loss, recording a negative EPS of $0.48 across the trailing twelve months.

Revenue climbed 25% to $11.1 billion, though the electric vehicle division has failed to satisfy market projections.

Other Wall Street voices express greater skepticism. Freedom Broker reduced its price objective to $22.00, referencing softening demand and escalating price wars in China. Barclays decreased its target to $14.00, highlighting flat to minimal single-digit delivery growth forecasts for Q3 2026.

Bernstein SocGen retained a Market Perform designation, revising its price target to $18.00 following expanded losses.

During Q2, XPeng posted revenue of RMB 19.7 billion, representing an 8% year-over-year increase and 51.5% sequential growth. Gross margin exceeded consensus projections, though adjusted net profit fell short of Bloomberg’s estimates.